Medicinal Cannabis Market is Estimated To Witness High Growth Owing To Legalization of Medical Cannabis
![]() |
Medicinal Cannabis Market |
Market Overview:
Medicinal cannabis, also known as medical marijuana,
refers to using the whole unprocessed marijuana plant or its basic extracts to
treat symptoms of illness and other conditions. It contains several
cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD), which
bind to cannabinoid receptors in the body and brain for therapeutic benefits.
Medicinal cannabis is prescribed for chronic pain, mental disorders such as
depression and anxiety, cancer, epilepsy, multiple sclerosis and other
conditions.
Market key trends:
One of the major market trends is the growing legalization of medical
cannabis across various countries. The legalization of medical cannabis has led
to immense availability and accessibility of medical cannabis, which is driving
the growth of this market. Many countries and U.S. states have legalized
medical cannabis after recognizing the medical benefits of cannabis for various
diseases and conditions. For instance, in 2019, Luxembourg became the first
country in Europe to legalize medical cannabis and cannabis derivatives.
Similarly, in 2022, Thailand legalized medical cannabis for medical purposes,
becoming the first country in Southeast Asia to do so. Such legalizations are
expected to boost the adoption of medical cannabis and fuel market growth over
the forecast period.
Porter’s Analysis
Threat of new entrants: The threat of Global
Medicinal Cannabis Market Demand is moderate due to high capital
requirement for R&D, marketing and distribution. However, several small
players are emerging due to legalization of cannabis in many countries.
Bargaining power of buyers: The bargaining power of buyers is high due to the
presence of various product alternatives. Buyers can easily switch to
substitutes based on quality and price.
Bargaining power of suppliers: The bargaining power of suppliers is moderate
due to availability of substitute raw materials. However, suppliers of
specialized extraction equipment have some bargaining power.
Threat of new substitutes: The threat of new substitutes is high with ongoing
research on new product formulations and delivery methods.
Competitive rivalry: High due to large number of players operating in the
market.
SWOT Analysis
Strength: Growing medical applications of cannabis and legalization in many
countries. Wide product portfolio with various consumption methods.
Weakness: Presence of substitutes. Stringent regulations in some regions.
Opportunity: Untapped growth potential in emerging markets. New product
innovations and strategic collaborations.
Threats: Negative social perception and complexity in clinical research.
Regulatory uncertainty in major markets.
Key Takeaways
The global Medicinal Cannabis market is expected to witness high growth at a
CAGR of 24% over the forecast period, due to increasing legalization in major
markets and growing application scopes. North America dominated the market in
2023 with highest number of cannabis dispensaries due to legalization in
countries like U.S and Canada.
Europe is also expected to be one of the fastest growing regional market owing
to increasing patient pool of chronic diseases and favorable regulatory
framework. Countries like Germany have emerged as the largest medicinal
cannabis market in Europe, exhibiting strong demand.
Key players operating in the medicinal cannabis market are BOL Pharma, Tilray,
Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys
Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited, GW
Pharmaceuticals, plc., and Medical Marijuana Inc. These players are focused on
new product launches, capacity expansions and mergers & acquisitions to
strengthen their market position.
Read
More:
https://www.dailyprbulletin.com/the-growth-of-medicinal-cannabis-market-share/
Comments
Post a Comment